About Adcendo
At Adcendo, we are developing a new generation of antibody-drug conjugates (ADCs) engineered to address cancers with high unmet medical need.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Undisclosed
Year Founded
2017
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
adcendo.com
Domain Registered Date
Jul 22, 2018
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $75,000,000 · Series-B+
fundraisingfox.com
- Milestone
Website domain registered
adcendo.com
- Milestone
Company founded
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Adcendo.
Funding History
Series-B+
· Apr 14, 2026
$75,000,000 fundraisingfox.com
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026